The U.S. Food and Drug Administration has granted Covidien 510(k) clearance to market the company’s Nellcor Bedside SpO2 Patient Monitoring System. The Nellcor Bedside SpO2 system with OxiMax ...
Covidien has announced it has received FDA clearance to market the Covidien Nellcor Bedside SpO2 Patient Monitoring System, according to a news release. The Nellcor Bedside SpO2 system includes the ...
Every year, nearly 7,200 infants are born in the United States with a Critical Congenital Heart Disease (CCHD).^1 It is a condition that is often easily detectable and, when discovered, quite ...